You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨藥品股拉昇 新華製藥一度大漲近16% 三生製藥漲5.6%
港股藥品股拉昇明顯,其中,山東新華製藥一度大漲近16%表現搶眼,天大藥業、德琪醫藥漲超6%,三生製藥、遠大醫藥漲5.6%,石藥集團、信達生物漲超2%。消息上,近一月以來,全國多地均出現新冠流行趨勢。“最近兩個月,我們確實感受到了新冠病毒感染有一定的擡頭趨勢,然而,這種變化並沒有達到顯著的規模,而是保持在了一個相對合理和可控的範圍內。”5月12日,來自北京、上海、廣州、武漢等多位感染科專家告訴記者,需要注意的是,對大多數年輕人而言,新冠病毒感染通常在3到5天內自行緩解,但老年人仍面臨重症風險,患病後仍不能掉以輕心。此外據悉,新華製藥是全球重要的解熱鎮痛藥物供應商,擁有布洛芬、阿司匹林、五安系列、美洛昔康等系列產品。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.